Pages
- A quality-driven CRO certified to ISO 9001 standard
- ATMP clinical trial specialists
- Broad-ranging therapeutic expertise
- Charities we support
- Client Testimonials
- Contact PHARMExcel CRO
- CRO for Biotech Clinical Studies
- Data Protection Policy
- Flexible and tailored services
- Let’s grow together.
- Medical device UK CRO
- Meet your next CRO Partner
- News and Events
- Our Commitment to a Safe and Respectful Workplace
- Our Commitment to Environmental, Social, and Governance (ESG)
- Our People
- Our Published Research
- PHARMExcel
- PHARMExcel cookie policy
- PHARMExcel Support Dementia UK
- PHARMExcel Support Macmillan
- PHARMExcel Support New Zion Christian Fellowship
- PHARMExcel Supports Alzheimer’s Research UK
- PHARMExcel Supports Isabel Hospice
- Site map
- The Ultimate PHARMExcel Glossary of Clinical Trials
- UK CRO for academic trials
- UK CRO Partner for Rare Disease Clinical Trials
Posts by category
- Category: Blogs
- PHARMExcel receives Top UK CRO Award
- PHARMExcel reports data for rare disease trials across 5 technologies
- Engaging patient and advocates in rare disease clinical trials
- PHARMExcel at 15: Looking Forward
- PHARMExcel celebrates 15 years’ CRO impact in clinical trials for NHS, investigator and biotech research
- PHARMExcel awarded for impactful CRO services in ophthalmology clinical trials
- Why choose an ISO 9001-compliant CRO?
- Your research, our priority: PHARMExcel’s commitment to delivering quality every time
- The challenges of financial forecasting in a growing CRO
- PHARMExcel’s newest paper in Frontline Gastroenterology is now available
- Forging paths: a closer look at rare disease clinical trials in the UK
- What does a world-class research site look like from a CRO-Sponsor perspective?
- A CEO reflection: raising the bar in clinical research outsourcing
- Staff spotlight: meet Allyson McLean – Head of Quality Assurance
- Case study: working with a world-class research site – Liverpool CRF
- Staff spotlight: meet Anshu Ahuja – Senior Operations Manager
- From ideas to commercialisation: 7 considerations for emerging life science techbios looking to scale up
- What are the 4 key values that underpin a successful CRO-Sponsor relationship?
- Staff spotlight: meet Margaret Irwin, Head of Clin Ops
- How PHARMExcel collaborated with ECMC to deliver a new revolutionary radiation therapy
- Finding the right CRO for your clinical trial – the five qualities to look for
- A year at PHARMExcel – investing in our people
- Collaboration is key – learnings from UKCRF Network’s 18th Annual Conference
- Secukinumab in Behcet’s trial: working towards a promising breakthrough for a rare autoimmune condition
- A year like no other: a reflection on 2022 from our CEO
- PHARMExcel wins businesswoman of the year award
- PHARMExcel expands quality and regulatory capabilities
- PHARMExcel recognised for investment in high performing workforce
- PHARMExcel wins Best Business of the Year
- Great teams don’t just happen
- How working with an agile CRO gets you more from your clinical trial budget
- PHARMExcel celebrates 13 successful years!
- New EU clinical trial regulation
- Yvanne Enever, Founder/CEO reflects on 2021
- PHARMExcel, a U.K. based CRO, is delighted to have been selected as the CRO to support the COVBoost study. Data has contributed to the MHRA approval decisions
- PHARMExcel to support trial delivery of world-first Covid-19 vaccine booster study.
- PHARMExcel instrumental in supporting the re-opening of Biotherapy Services DFU trial
- PHARMExcel selected as INmuneBio’s UK CRO to lead on their Phase I clinical trial of INKmune in MDS patients
- Effective CRO project management and fast track study set-up for an investigator initiated COVID-19 study
- Category: Case Study
- PHARMExcel – Lessons learned from UK CRO partnering on a landmark NHS vaccine clinical trial
- The world’s first mental health treatment using ultrasound
- ATMP Oncology Study: The first-in man trial for a Biotech’s novel therapy to prime the patient’s natural killer cells to attack their cancer
- PHARMExcel and Moorfields Eye Hospital: a visionary partnership in ophthalmology clinical research
- Case study: liver dialysis device, DIALIVE, proves safe and effective
- Adopting a new agile approach to CRO clinical trial management
- Category: Charity
- October marks Day 1 for our 100k run challenge
- PHARMExcel do Bake Off
- Dani Harrison completes her 2 mile Serpentine swim in aid of Macmillan Cancer Support
- PHARMExcel’s HR Manager, Dani Harrison, takes on the Serpentine Swim for our chosen Charity
- PHARMExcel’s fundraising events 2021
- PHARMExcel’s chosen charity for 2021 is Macmillan Cancer Support
- The PHARMExcel team deliver food hampers to one of their local Food Banks
- Category: Events & Awards
- A Guide to Medical Device Regulation Webinar
- PHARMExcel presents vaccine study learnings at World Congress 2025
- PHARMExcel Shortlisted for SCRIP Awards 2025 as Best Specialist CRO
- PHARMExcel Nominated for Most Impactful Industry Collaboration at OBN Awards 2025
- PHARMExcel CEO to speak at Grand Rounds Europe 2025 in Cambridge
- PHARMExcel listed in Top 10 Oncology Service Providers 2025
- PHARMExcel supports clinical-stage medtechs at SEHTA Conference
- PHARMExcel CRO champions Fabry, MPS, and rare disease communities through year-round support and awareness initiatives
- PHARMExcel named finalist in Healthcare Technology Award for medical device trial
- PHARMExcel engages in key discussions at the 21st WORLD Symposium for rare disease research
- PHARMExcel CEO to talk at Clinical Outsourcing Strategies Conference 2025
- PHARMExcel nominated Best Contract Research Organisation (Specialist Providers) by SCRIP Awards 2024
- PHARMExcel named finalist for Most Impactful CRO of the Year at OBN Awards
- PHARMExcel’s CEO returns to speak at Clinical Outsourcing Group Conference 2024
- PHARMExcel awarded Gold by Investors in People
- PHARMExcel secures top 5 spot among clinical management solutions providers in the UK
- PHARMExcel’s CEO, Yvanne Enever, to speak at UK Industry Leaders Think Tank
- PHARMExcel to exhibit at 10th Annual Outsourcing in Clinical Trials UK and Ireland
- PHARMExcel to attend UKCRFN Annual Conference 2023
- PHARMExcel sponsors NHS R&D Forum 2023
- PHARMExcel to speak at Clinical Outsourcing Group Conference
- Meet PHARMExcel at IIS 2023!
- PHARMExcel shortlisted in the Investors in People Awards 2022
- PHARMExcel CEO nominated for Best Businesswoman of the Year Award
- PHARMExcel shortlisted to win Business of the Year Award
- Reward & Recognition Award – Arturo Maldonado
- Category: Meet The Team
- Category: News & Studies
- PHARMExcel teams volunteer for a good cause – The Apprentice style!
- PHARMExcel named among the best CRO specialist providers
- Tackling UK decline in clinical trials: PHARMExcel welcomes launch of Talent Taskforce
- We’re excited to announce that PHARMExcel is now a proud member of the Hertfordshire Chamber of Commerce (HCC).
- PHARMExcel welcomes new MHRA Corporate Plan 2023-2026
- PHARMExcel joins forces with BIA to expand biotech horizons
- PHARMExcel announces publication of its COV-BOOST paper in Journal of Infection
- Proud to announce we are ISO 9001 certified!
- PHARMExcel appoints Russell Wheatcroft as Chief Operating Officer
- Yvanne Enever named Businesswoman of the Year
- PHARMExcel are pleased to announce their latest Lancet publication on Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters
- PHARMExcel are pleased to announce the publication of the persistence of immunogenicity after seven Covid -19 vaccines given as third boosters
- PHARMExcel are delighted to announce their future collaboration with DIOSynVax to support the delivery of their forthcoming clinical trial program.
- PHARMExcel delighted to be the selected U.K. CRO delivering this pivotal clinical trial alongside colleagues at University Southampton, Cambridge and DIOSynVax.
- PHARMExcel are pleased to announce the publication of the safety and immunogenicity data from the UK’s Covboost trial.
- Covid booster jabs will begin to be offered across the UK from next week based on JCVI decisions following COVBoost clinical trial data.
- PHARMExcel supports recruitment of the first patient into INmuneBio’s pivotal MDS study showing promising results
- Initial covboost study data ready for analysis..
- PHARMExcel running MDS trial that sees first patient treated
- Covid: Bradford NHS consultant first in world to receive booster vaccine
- UK records zero Covid daily deaths as scientists warn of third wave
- Sanofo-GSK vaccine showing positive Phase II data
- Increasing confidence jabs work against Indian variant
- US approves Pfizer COVID-19 vaccine for children aged 12 to 15
- New NHS legislation provides ‘once-in-a-decade opportunity’ to centre research
- Moderna becomes third Covid vaccine approved in the UK
- Covid-19